AD1208

· Avelos Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD1208, covering 2025-04-04 to 2025-04-04. Get the full timeline:

Most recent: Clinical Trial Update: AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]